Long-term results of a phase I/II study of high-dose thoracic radiotherapy with concomitant cisplatin and etoposide in limited stage small-cell lung cancer

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 24, Issue 6, 2001, Pages 556-561

  Brown, Paul D ^a   Bonner, James A ^b   Foote, Robert L ^a   Frytak, Stephen ^a   Marks, Randolph S ^a   Richardson, Ronald L ^a   Creagan, Edward T ^a  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Chemotherapy; Limited stage; Prospective trial; Radiotherapy; SCLC

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; ETOPOSIDE;

ACUTE NONLYMPHOCYTIC LEUKEMIA; ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER RECURRENCE; CLINICAL ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; LONG TERM CARE; LUNG SMALL CELL CANCER; MALE; METASTASIS; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; RADIATION DOSE; RADIATION DOSE FRACTIONATION; SIDE EFFECT;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRAIN NEOPLASMS; CARCINOMA, SMALL CELL; CISPLATIN; COMBINED MODALITY THERAPY; CRANIAL IRRADIATION; CYCLOPHOSPHAMIDE; DISEASE-FREE SURVIVAL; DOSE FRACTIONATION; ETOPOSIDE; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED;

EID: 0035213627     PISSN: 02773732     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000421-200112000-00005     Document Type: Article

References (31)

1. Accelerated hyperfractionated split-course thoracic radiotherapy (AHSCTRT) and infusion cisplatin based chemotherapy (CT) for small cell lung cancer (SCLC)
2. Evaluation of response criteria in advanced lung cancer
3. Nonparametric estimation from incomplete observations
4. Etoposide-related acute promyelocytic leukemia
5. Acute promyelocytic leukemia after treatment for non-Hodgkin's lymphoma with drugs targeting topoisomerase II
6. Secondary acute myeloid leukemia following treatment with VP16-containing regimens for non-Hodgkin's lymphoma
7. Standard- and highdose etoposide, ifosfamide, carboplatin, and epirubicin in 100 patients with small-cell lung cancer: A mature follow-up report
8. Therapy-related leukemia and myelodysplasia following oral administration of etoposide for recurrent breast cancer
9. Secondary leukemia or myelodysplastic syndrome after treatment with epipodophyllotoxins
10. Secondary leukemia following high cumulative doses of etoposide in patients treated for advanced germ cell tumors
11. The price of success
12. Etoposide and antimetabolite pharmacology in patients who develop secondary acute myeloid leukemia
13. Epipodophyllotoxin-related leukemia. Identification of a new subset of secondary leukemia
14. Infusion cisplatin chemotherapy and hyperfractionated thoracic radiotherapy for small-cell lung cancer
15. Small cell anaplastic carcinoma of lung. Reappraisal of current management
16. The relationship of infield recurrences to prescribed tumor dose in small cell carcinoma of the lung
17. The influence of radiation therapy quality control on survival, response and sites of relapse in oat cell carcinoma of the lung: Preliminary report of a Southwest Oncology Group study
18. Importance of radiation dose in achieving improved loco-regional tumor control in limited stage small-cell lung carcinoma: An update
19. The effect of dose of thoracic irradiation on recurrence in patients with limited stage small cell lung cancer. Initial results of a Canadian Multicenter Randomized Trial
20. Leukemia in atomic bomb survivors, Hiroshima and Nagasaki, 1 October 1950-30 September 1966
21. Mortality from cancer and other causes after radiotherapy for ankylosing spondylitis
22. Risk of leukemia after chemotherapy and radiation treatment for breast cancer
23. Leukemia following Hodgkin's disease
24. Therapy-related leukemia and myelodysplastic syndrome in breast cancer patients treated with cyclophosphamide or anthracyclines
25. Further evaluation of intensified and increased total dose of cyclophosphamide for the treatment of primary breast cancer: Findings from National Surgical Adjuvant Breast and Bowel Project B-25
26. Risk of leukemia after platinum-based chemotherapy for ovarian cancer
27. Limited-stage small-cell lung cancer: Patterns of intrathoracic recurrence and the implications for thoracic radiotherapy
28. Phase III comparison of twice-daily split-course irradiation versus once-daily irradiation for patients with limited stage small-cell lung carcinoma
29. Randomized trial of alternating versus sequential radiotherapy/chemotherapy in limited-disease patients with small-cell lung cancer: A European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group Study
30. Combination chemotherapy with or without thoracic radiotherapy in limited-stage smallcell lung cancer: A randomized trial of the Southeastern Cancer Study Group
31. Twice-daily compared with once-daily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etoposide